The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database. - Gorelik E; Gorelik B; Masarwa R; Perlman A; Hirsh-Raccah B; Matok I (International journal of obesity (2005), 2020)